News und Analysen
Kohl’s Corporation: This Offprice Retailer Is Ready To Rally
Kohl’s Corporation (NYSE: KSS) stock price has been wallowing near long-term lows despite signs of turnaround and an improving outlook for cash flow. This market needs a catalyst to get it moving
Nvidia's Soaring Success: Too Late to Buy?
At the forefront of the market surge stands Nvidia (NASDAQ: NVDA), continuing its meteoric rise into the new year. Last year’s champion stock has wasted no time in extending its winning streak,
What Dip, Nu Holdings Stock Continues to Rise After Earnings Miss
Nu Holdings Ltd. (NYSE: NU) stock is up 119% in the last 12 months. However, investors hoping for a pullback after the company's slight miss on earnings will have to wait. Since the Latin
3 Stocks Showing Constructive Pullbacks with Indexes at New Highs
One of the most exciting things for an investor or trader is to look at tier account statement, or at the charts of what they own, and see a stock like Nvidia Corp. (NASDAQ: NVDA) or even the
Zscaler Stock Price Plunges: Buy the Dip Candidate
Zscaler (NASDAQ: ZS) had a robust Q2 and raised its guidance, but it was not enough to lift the market. The results and valuation suggest the stock is priced to perfection following the
3 Hot Stocks Bought by Members of Congress: Follow the Money
The STOCK Act of 2012 was supposed to halt insider trading by members of Congress, but let’s be honest. The STOCK Act can’t really stop Congresspeople from trading on insider knowledge; they’re in
Eilt: Sensationelle Studienergebnisse - 100 mal wirksamer gegen Krebs. Neuer 503% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Sensationelle Studienergebnisse - 100 mal wirksamer gegen Krebs. 503% Biotech Aktientip nach 134.452% mit Biogen
01.03.24 08:03
London (www.aktiencheck.de, Anzeige)
Salesforce.com Stock Will Set a New High This Year
Salesforce.com’s (NYSE: CRM) stock price is having trouble with traction following the Q4 results and guidance, but a massive correction is not expected for this tech stock. The results did not
bluebird bio Stock Signals Potential to be a Multi-bagger
It isn’t often that you can find the right story at the right time to give you a good chance of multiplying your wealth; these so-called multi-bagger stocks get their name because their price sees
Wendy's Walks Back Surge Pricing Talk After Social Media Grilling
Wendy’s Company (NASDAQ: WEN) stock traded nearly 2% higher on February 28 as the fast-food mid-cap said it would not raise prices at times of high demand.
The turnaround came after Wendy’s CEO
CarGurus Stock is Set for a Rally This Quarter, Above all Peers
Some businesses could soon see the bullish side effects of a resilient consumer amongst the pretext of potential interest rate cuts coming this year from the FED. According to the FedWatch tool at
Eilt: 100 mal wirksamer gegen Krebs - Blockbuster gegen Krebs. Massives Kaufsignal.Neuer 503% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: 100 mal wirksamer gegen Krebs - Blockbuster gegen Krebs. 503% Biotech Hot Stock nach 15.973% mit BioNTech ($BNTX)
29.02.24 08:02
London (www.aktiencheck.de , Anzeige)
How to Use Credit Spreads to Make Income from Options
If you are bullish on any optionable stock in any stock sector, you can play any number of options trades. The easiest directional strategy is to buy a call option. However, you will fight time
Insider selling at JPM: A Closer Look Amidst Historic CEO Sale
The recent insider selling activity at JPMorgan Chase & Co. (NYSE: JPM), a leading banking and financial institution, has drawn notable attention, with CEO Jamie Dimon making his first-ever stock
Workday Stock Price is Working on a Buy-the-Dip Opportunity
Workday, Inc. (NASDAQ: WDAY) issued a lackluster FQ2 report that left the market wishing for more. However, as tepid as the results are, underperformance is relative to analysts' consensus
Palantir Stock Has It all… Except the Analysts' Support
Palantir Technologies (NYSE: PLTR) stock is gaining traction and may advance another 50% or more in the next few months. The company has a solid product, growing demand, deepening penetration and
3 wealth-compounding stocks to beat the market this decade
Because the Federal Reserve (the Fed) has announced potential interest rate cuts for this year, an expectation priced in for March is now being pushed as far back as May or June, according to the
Sensationelle Studienergebnisse - 100 mal wirksamer gegen Krebs. Neuer 525% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Sensationelle Studienergebnisse - 100 mal wirksamer gegen Krebs. 525% Biotech Hot Stock nach 9.290% mit Novo-Nordisk
28.02.24 08:03
London (www.aktiencheck.de, Anzeige)
Autozone stock price is still in the rally zone
Autozone (NYSE: AZO) shares surged following the FQ2 report, confirming the uptrend is intact. Because the news aligns with the outlook for growth and capital returns, the trend will likely
Westward Gold Outlines 2024 Exploration Goals at Cortez Trend Properties
Vancouver, British Columbia, February 27, 2024 – Westward Gold Inc. (CSE: WG, OTCQB: WGLIF, FSE: IM50) (“Westward” or the “Company”) is pleased to provide preliminary details surrounding
New highs are coming for Lowe’s stock despite mixed results
At face value, Lowe’s Companies (NYSE: LOW) had a rough Q4 compared to competitor Home Depot, but the details within the report belie that assessment. Comps were weak, but the company is building
3 lithium stocks to ride a multi-year cycle
The world used to run on coal and other types of fuel that powered the different titans of industry. This cycle started with transportation through railways to factories and steel mills that were
Goldman upgraded Nvidia stock, one metric says it could go higher
Today's market seems to be all over the hype stories found in the world of technology stocks. This is especially the case with blowout performances by names like Nvidia Corporation (NASDAQ: NVDA)
bluebird bio: How to play LEAPS options for growth and income
Gene-editing is making huge headlines in the medical sector stemming from the first FDA approval for a CRISPR/cas9 treatment for sickle cell disease SCD and TDT from CRISPR Therapeutics AG
Thinking long-term? Don't lose interest in Pinterest
Pinterest Inc. (NYSE: PINS) stock suffered a 12% sell-off on its Q4 2023 earnings report. The main reason for the selling was a miss on the top line, as revenues failed to beat consensus analyst